MRS Bulletin
Back to Journals Drug Design, Development and Therapy Volume 19 A Comprehensive Review on the Pharmacokinetics and DrugDrug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist Authors Min JS, Jo SJ, Lee S, Kim DY, Kim DH, Lee CB , Bae SK Received 17 November 2024 Accepted for publication 14 April 2025 Published 30 April 2025 Volume 2025:19 Pages 35093537 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
Aducanumab: First Approval
Express Scripts vs Cigna Evernorth: the 2024 merger and what changed In December 2023, Cigna completed its acquisition of Express Scripts' parent company, merging Express Scripts with Cigna's existing pharmacy benefit manager, Evernorth
Monitoring Thyroid Function During Treatment When starting semaglutide, clinicians often check TSH, free T4, and free T3 every 612 weeks
With the best price, Balkan Pharma products guarantee maximum quality